Brief: Century Therapeutics Provides Pipeline Updates
11/11/2022 12:15
Nov 11 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS ANNOUNCES PRESENTATION OF PRECLINICAL
DATA
AT THE SITC 37TH ANNUAL MEETING AND PROVIDES PIPELINE UPDATES
* CENTURY THERAPEUTICS INC - COMPANY ANNOUNCES NOMINATION OF
NEXT
PIPELINE PROGRAM, CNTY-107 A NECTIN-4 CAR GAMMA DELTA IT PRODUCT
CANDIDATE
* CENTURY THERAPEUTICS INC - EXPECTS TO FILE AN
INVESTIGATIONAL
NEW DRUG (IND) APPLICATION IN 2025 FOR NECTIN-4+ CANCERS
Source text for Eikon: ID:nGNX31qsdb
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview